Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,460 | 76,677 | 84,833 | 94,041 | 101,133 |
| TOTAL | $72,788 | $79,325 | $88,346 | $95,558 | $102,582 |
| Non-Current Assets | |||||
| Intangibles | 48,648 | 48,648 | 48,648 | 48,648 | 48,648 |
| Other Non-Current Assets | 33,270 | 33,405 | 33,554 | 32,964 | 33,075 |
| TOTAL | $81,918 | $82,053 | $82,202 | $81,612 | $81,723 |
| Total Assets | $154,706 | $161,378 | $170,548 | $177,170 | $184,305 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,318 | 1,026 | 1,813 | 1,598 | 857 |
| Accrued Expenses | 1,671 | 1,604 | 2,219 | 2,271 | 1,641 |
| TOTAL | $3,276 | $2,958 | $4,401 | $4,046 | $2,677 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 299 | 350 | 400 | 45 | 90 |
| TOTAL | $2,051 | $2,102 | $2,152 | $2,376 | $3,107 |
| Total Liabilities | $5,327 | $5,060 | $6,553 | $6,422 | $5,784 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,757 | 13,757 | 14,307 | 14,307 | 14,307 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -134,010 | -124,763 | -114,899 | -106,093 | -96,276 |
| TOTAL | $149,379 | $156,318 | $163,995 | $170,748 | $178,521 |
| Total Liabilities And Equity | $154,706 | $161,378 | $170,548 | $177,170 | $184,305 |